Lakeshore biopharma to hold an extraordinary general meeting of shareholders on september 27, 2024

Gaithersburg, md. , sept. 10, 2024 /prnewswire/ -- lakeshore biopharma co., ltd (nasdaq: lsb) ("lakeshore biopharma" or the "company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it will hold an extraordinary general meeting of shareholders (the "egm") at 10:00 a.m.
GM Ratings Summary
GM Quant Ranking